Our in vitro data confirmed previous studies which demonstrated its role in the EMT of pancreatic cancer cells as well as its cellular downstream effects by targeting ZEB1 and TWIST1 [11, 42, 43]. The gene discussed is ZEB1; the disease is pancreatic neoplasm.